BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Janssen Pharmaceutical K.K. 

Takanawadai Daiichi-Seimei Building 1-5
Higashi-Gotanda 3-chome
Shinagawa-ku    141  Japan
Phone: 81-3-3445-221 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
AstraZeneca PLC (AZN) to Co-Promote Janssen Pharmaceutical K.K.'s Prostate Cancer Drug in Japan 10/11/2013 6:57:15 AM    More...
Janssen Pharmaceuticals, Inc. Confirms XARELTO® is as Effective as the Standard of Care in Treatment of DVT and PE 9/20/2013 7:02:56 AM    More...
Johnson & Johnson (JNJ) Handed a Federal Subpoena Over Nucynta Marketing 8/5/2013 7:19:31 AM    More...
Janssen Pharmaceutical K.K. and Taiwan University Team Up to Fight Hepatitis B 6/5/2013 9:06:40 AM    More...
Janssen Pharmaceutical K.K. Opens R&D Center in Shanghai 2/6/2013 10:21:08 AM    More...
NGM Biopharmaceuticals, Inc., Janssen Pharmaceutical K.K. Form Alliance for Undisclosed Amount 1/3/2013 8:05:32 AM    More...
Evotec AG (EVTG.F), Janssen Pharmaceutical K.K. Sign License Agreement for Up to $175 Million 12/17/2012 7:26:16 AM    More...
FDA Approves Janssen Pharmaceutical K.K.'s NUCYNTA® ER (tapentadol) Extended-Release Oral Tablets for Neuropathic Pain 8/29/2012 7:01:54 AM    More...
Janssen Pharmaceutical K.K. Release: Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 5/18/2012 10:55:53 AM    More...
Watson Pharmaceuticals, Inc. (WPI) Reaches Settlement With Janssen Pharmaceutical K.K. Over ORTHO TRI-CYCLEN(R) LO 2/8/2012 10:55:13 AM    More...
12

//-->